September 21, 2012 — Cardionovum GmbH announced that the results of a preclinical study and a first-in-man clinical study of its Primus drug-coated balloon (DCB) will be published in the October issue of Minerva Cardioangiologica, the journal of the Italian Society of Angiology and Vascular Pathology and of the Italian Society of Vascular Diagnostics.

September 20, 2012 — Hospitals, medical facilities, doctors and long-term care facilities this fall are stocking shelves and purchasing items from their wish list and budgets before a new tax on most medical products goes into effect in 2013.

September 20, 2012 — Boston Scientific Corp. has signed a definitive agreement to acquire BridgePoint Medical Inc., a privately held company based in Minneapolis. BridgePoint Medical has developed a proprietary, catheter-based system to treat coronary chronic total occlusions (CTOs).

In a recent article, “The AMA Backs Bills to Stop Medicare Imaging Pay Cuts,”  the American Medical Association (AMA) once again is fighting to maintain the status quo. They’ve picked a battle that won’t help them win the war.

Wayne Webster is a business development healthcare consultant. You can learn more about Webster and his company, Proactics Consulting, at www.Proactics.net. You can reach Webster at [email protected].

September 19, 2012 — Heart catheter procedures guided by magnetic resonance imaging (MRI) are as safe as X-ray angiography-guided procedures and take no more time, according to a pilot study conducted at the National Institutes of Health (NIH). The results of the study indicate that real-time MRI-guided catheterization could be a radiation-free alternative to certain X-ray-guided procedures.

September 19, 2012 — Merge Healthcare Inc. announced that its board of directors has retained Allen & Company LLC, a New York-based investment bank, to assist in exploring and evaluating a broad range of strategic alternatives including, but not limited to, a sale of the company or a business combination.

Subscribe Now